NCT04882839 |
|
Evaluating the Feasibility Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe OCD
|
View
|
NCT01076855 |
|
Guidance for Elderly With Cognitive Disorders
|
View
|
NCT01769027 |
|
Antibiotic Treatment and Intravenous Immunoglobulin Trial for PANDAS
|
View
|
NCT02750189 |
|
The Economic Burden of Chronic Obstructive Pulmonary DiseaseCOPD in South Korea
|
View
|
NCT03010761 |
|
Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Oral Pre-cancer
|
View
|
NCT03754647 |
|
Effect of Vitamin C Upon SSRI-treated OCD Patients
|
View
|
NCT05388331 |
|
RIS International Cohort
|
View
|
NCT05841017 |
|
Immersive Virtual Reality Obsessive Compulsive Disorder
|
View
|
NCT06231095 |
|
Does TMS Affect Neuroplasticity The Role of Brain-derived Neurotrophic Factor and Neuronal Cell Adhesion Molecules - an Intensive Clinical Protocol Among Patients With Obsessive-compulsive Disorders
|
View
|
NCT06244121 |
|
Effect of Pyridoxine as Add-on Therapy in OCD Patients
|
View
|
NCT00423670 |
|
Safety and Efficacy of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 Study P03523
|
View
|
NCT01425203 |
|
The Effect of Boceprevir in Russian Participants Diagnosed With Chronic Hepatitis C Genotype 1 P08160
|
View
|
NCT01446250 |
|
Alisporivir Deb025 and Boceprevir Triple Therapies in African American Participants Not Previously Treated for Chronic Hepatitis C Genotype 1
|
View
|
NCT01499498 |
|
The Boceprevir and Sildenafil Pharmacokinetics Study
|
View
|
NCT01945294 |
|
Short Duration Versus Standard Response-Guided Therapy With Boceprevir Combined With PegIntron and Ribavirin in Previously Untreated Non-Cirrhotic Asian Participants With Chronic HCV Genotype 1 MK-3034-107
|
View
|
NCT01555970 |
|
Efficacy Study of add-on Therapy With N-Acetylcysteine in Resistant Obsessive-compulsive Disorder
|
View
|
NCT00723060 |
|
Comparison of Effects Between Conventional Dose and High Dose Escitalopram on Clinical Improvement in Patients With Obsessive-compulsive Disorder
|
View
|
NCT01718301 |
|
HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon Ribavirin
|
View
|
NCT01482767 |
|
Evaluating the Effectiveness of Boceprevir Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus HCV Infection in Adults With HIV and HCV Infection
|
View
|
NCT01813019 |
|
Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder OCD Patients Resistant to Selective Serotonin Reuptake Inhibitor SSRI Therapy
|
View
|
NCT01925183 |
|
Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C
|
View
|
NCT01933919 |
|
A Phase 3 Study of Fluvoxamine SME3110 in PediatricAdolescent Patients With Obsessive Compulsive Disorder
|
View
|
NCT05401019 |
|
Efficacy of Treatment With Pramipexole or Risperidone in Patients With Refractory Obsessive-compulsive Disorder OCD
|
View
|
NCT03217123 |
|
Deep-brain Stimulation in Obsessive-compulsive Disorder Randomized Double-blinded Clinical Trial
|
View
|
NCT04648007 |
|
Validation of Kaihani Score for Gambling Addiction
|
View
|
NCT01035242 |
|
Association Splitting in Obsessive-Compulsive Disorder OCD
|
View
|
NCT01390844 |
|
Safety and Efficacy of Boceprevir in Asia Pacific Participants With Chronic Hepatitis C Genotype 1 P07063
|
View
|
NCT06445101 |
|
VitalWork an Intervention for Prevention of Mental Health Complaints at Work
|
View
|
NCT00106249 |
|
Transcranial Magnetic Stimulation TMS and Obsessive Compulsive Disorder OCD
|
View
|
NCT02204475 |
|
Grazoprevir MK-5172Elbasvir MK-8742 Versus BoceprevirPegylated InterferonRibavarin for Chronic Hepatitis C Infection MK-5172-066
|
View
|
NCT00956085 |
|
Memantine Augmentation in Treatment-Resistant Adults With Obsessive-Compulsive Disorder
|
View
|
NCT00994786 |
|
A Study of Pregabalin Lyrica Augmentation in Serotonin Reuptake Inhibitor-Refractory Obsessive Compulsive Disorder
|
View
|
NCT01457937 |
|
BoceprevirPegIFN α-2bRiba in HCV Gt1 Menopausal Women Nonresponders to PegIFNRiba or Treatment-naives MEN_BOC
|
View
|
NCT01544920 |
|
Safety and Efficacy of BoceprevirPeginterferon Alfa-2aRibavirin in Interleukin-28B CC Allele-Positive Chronic Hepatitis C Virus HCV Genotype 1 Participants P07755
|
View
|
NCT00689390 |
|
Three-year Follow-up of Participants After Administration of Boceprevir or Narlaprevir for the Treatment of Chronic Hepatitis C P05063
|
View
|
NCT00708396 |
|
Tolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia And Obsessive-Compulsive Disorder OCD - An Open Label Study
|
View
|
NCT00869505 |
|
Study of Memantine Augmentation in Severe Obsessive-Compulsive Disorder
|
View
|
NCT00910624 |
|
Boceprevir Treatment in Participants With Chronic Hepatitis C Genotype 1 Deemed Nonresponders to PeginterferonRibavirin P05514
|
View
|
NCT02511392 |
|
Repetitive Transcranial Magnetic Stimulation in the Treatment of Obsessive Compulsive Disorders
|
View
|
NCT02758509 |
|
Impact of Antiviral Therapy on Gastroesophageal Varices
|
View
|
NCT03207633 |
|
Low Frequency TMS on DLPFC and OFC in OCD Patients
|
View
|
NCT03767491 |
|
Waitlist-Control Trial of Smartphone CBT for Obsessive-Compulsive Disorder OCD
|
View
|